참고문헌
- Atanackovic D, Luetkens T, Kloth B, et al (2011). Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. Am J Hematol, 86, 918-22. https://doi.org/10.1002/ajh.22141
- Cen YH, Guo WW, Luo B, et al (2012). Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells. Cell Biol Int, 36, 917-22. https://doi.org/10.1042/CBI20120037
- Chan WI, Huntly BJ (2008). Leukemia stem cells in acute myeloid leukemia. Semin Oncol, 35, 326-35. https://doi.org/10.1053/j.seminoncol.2008.04.003
- Costello RT, Rey J, Fauriat C, Gastaut JA, Olive D (2003). New approaches in the immunotherapy of haematological malignancies. Eur J Haematol, 70, 333-45. https://doi.org/10.1034/j.1600-0609.2003.00065.x
- Ghafouri-Fard S, Abdollahi DZ, Omrani M, Azizi F (2012). shRNA mediated RHOXF1 silencing influences expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 cell lines. Asian Pac J Cancer Prev, 13, 5865-9. https://doi.org/10.7314/APJCP.2012.13.11.5865
- Ghafouri-Fard S, Modarressi MH (2009). Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med, 12, 395-404.
- He G, Chen L, Ye Y, et al (2010). PIWIL2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16. Am J Transl Res, 2, 156-69.
- Lee JH, Schutte D, Wulf G, et al (2006). Stem-cell protein PIWIL2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet, 15, 201-11.
- Lim SH, Zhang Y, Zhang J (2012). Cancer-testis antigens: the current status on antigen regulation and potential clinical use. Am J Blood Res, 2, 29-35.
- Liu JJ, Shen R, Chen L, et al (2010). PIWIL2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol, 3, 328-37.
- Meklat F, Li Z, Wang Z, et al (2007). Cancer-testis antigens in haematological malignancies. Br J Haematol, 136, 769-76. https://doi.org/10.1111/j.1365-2141.2006.06484.x
- Mukda E, Pintaraks K, Sawangpanich R, Wiangnon S, Pakakasama S (2011). FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia. Asian Pac J Cancer Prev, 12, 1827-31.
- Shibata-Minoshima F, Oki T, Doki, N, et al (2012). Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning. Int J Oncol, 40, 93-8.
- Ono T, Kurashige T, Harada N, et al (2001). Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA, 98, 3282-7. https://doi.org/10.1073/pnas.041625098
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Tabarestani S, Ghafouri-Fard S (2012). Cancer stem cells and response to therapy. Asian Pac J Cancer Prev, 13, 5951-8.
- Yazarloo F, Shirkoohi R, Mobasheri MB, Emami A, Modarressi MH (2013). Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern. Med Oncol, 30, 368. https://doi.org/10.1007/s12032-012-0368-8
- Yin DT, Wang Q, Chen L, et al (2011). Germline stem cell gene PIWIL2 mediates DNA repair through relaxation of chromatin. PLoS One, 6, 27154. https://doi.org/10.1371/journal.pone.0027154
- Zou Y, Zhong W (2012). A likely role for a novel PH-domain containing protein, PEPP2, in connecting membrane and cytoskeleton. Biocell, 36, 127-32.
피인용 문헌
- Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy vol.9, pp.12, 2017, https://doi.org/10.2217/imt-2017-0083
- Melanoma: a prototype of cancer-testis antigen-expressing malignancies vol.9, pp.13, 2017, https://doi.org/10.2217/imt-2017-0091